There were plenty of interested media in BASF's Scottish omega-3 venture.
Salmond told us: "In many ways we always love to have Scottish companies (referring to Equateq) but in terms of the world-wide promotion of this product, a company with BASF's strength as one of the great chemical companies on the planet, there are big advantages."
"I saw the original process machinery and now the machinery that has been installed here - it is a 100-fold increase in production. So to unleash the full potential it needed the strength of a major company. But we have the great satisfaction of knowing these processes have been developed by Scottish scientists and in this case, by an Isle of Lewis man [Angus Morrison]."
in-Pharmatechnologist.com takes a look at the People on the Move this week.
The WHO Executive Board prepares for a special Ebola meeting, CEO leaves troubled biotech, and senior staff...
Novartis's CEO becomes President of EFPIA, a new head of R&D for Genentech, and more People on...